4.5 Interaction with other medicinal prod ucts and other fo rms of interaction  
 Hexacima can be administered simu ltaneously with a pne umococcal polysaccharide conjugate vaccine, measles, mumps, rubella (MMR) and varicella -containing  vaccines, rotavirus vaccine s, a meningococcal C conjugate vaccine or a meningococca l group A, C, W -135 and Y conjuga te vaccine, as no cl inically relevant int erference in the antibody response to each of the antigens has been shown.  
 If co-administration with another vaccine is consi dered, immunisation should be carried o ut on separate i njection sites.  
 Hexacima  must n ot be mixed with any other vaccines or oth er parenterally administered medicinal products . 
 No significant clinical interaction with other treatments or biological prod ucts has been reported  except in the ca se of immunosupp ressive therapy (see section 4.4) . 
 For interference with  laboratory testing , see section  4.4. 
 
